Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ole Kirk

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|August 19, 2005
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapyJürgen K Rockstroh, Amanda Mocroft, Vincent Soriano, et al.
Journal of Clinical Epidemiology|December 18, 2007
Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trialAnn-Brit Eg Hansen, Jan Gerstoft, Ole Kirk, et al.
AIDS (London, England)|July 2, 2014
Deteriorating renal function and clinical outcomes in HIV-positive personsAmanda Mocroft, Lene Ryom, Josip Begovac, et al.
AIDS (London, England)|July 12, 2012
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patientsLars Peters, Daniel Grint, Jens D Lundgren, et al.
Plos One|February 13, 2019
Serum creatinine and estimated glomerular filtration rates in HIV positive and negative adults in EthiopiaDaniel Yilma, Alemseged Abdissa, Pernille Kæstel, et al.
BMC Infectious Diseases|August 9, 2020
Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovirDaniel Yilma, Alemseged Abdissa, Pernille Kæstel, et al.
AIDS (London, England)|April 2, 2005
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortDeborah Konopnicki, Amanda Mocroft, S de Wit, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
HIV Clinical Trials|April 19, 2011
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA studyJustyna D Kowalska, Amanda Mocroft, Bruno Ledergerber, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|August 19, 2005
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapyJürgen K Rockstroh, Amanda Mocroft, Vincent Soriano, et al.
Journal of Clinical Epidemiology|December 18, 2007
Unmeasured confounding caused slightly better response to HAART within than outside a randomized controlled trialAnn-Brit Eg Hansen, Jan Gerstoft, Ole Kirk, et al.
AIDS (London, England)|July 2, 2014
Deteriorating renal function and clinical outcomes in HIV-positive personsAmanda Mocroft, Lene Ryom, Josip Begovac, et al.
AIDS (London, England)|July 12, 2012
Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patientsLars Peters, Daniel Grint, Jens D Lundgren, et al.
Plos One|February 13, 2019
Serum creatinine and estimated glomerular filtration rates in HIV positive and negative adults in EthiopiaDaniel Yilma, Alemseged Abdissa, Pernille Kæstel, et al.
BMC Infectious Diseases|August 9, 2020
Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovirDaniel Yilma, Alemseged Abdissa, Pernille Kæstel, et al.
AIDS (London, England)|April 2, 2005
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohortDeborah Konopnicki, Amanda Mocroft, S de Wit, et al.
AIDS (London, England)|November 5, 2008
Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?Joanne Reekie, Amanda Mocroft, Helen Sambatakou, et al.
Antiviral Therapy|November 30, 2005
Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?Amanda Mocroft, Jurgen Rockstroh, Vincent Soriano, et al.
HIV Clinical Trials|April 19, 2011
A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA studyJustyna D Kowalska, Amanda Mocroft, Bruno Ledergerber, et al.
Pageof 18